日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Combined presentation and immunogenicity analysis reveals a recurrent RAS.Q61K neoantigen in melanoma

联合呈现和免疫原性分析揭示黑色素瘤中复发的 RAS.Q61K 新抗原

Aviyah Peri, Erez Greenstein, Michal Alon, Joy A Pai, Tamir Dingjan, Shlomit Reich-Zeliger, Eilon Barnea, Chaya Barbolin, Ronen Levy, Claudia Arnedo-Pac, Shelly Kalaora, Bareket Dassa, Ester Feldmesser, Ping Shang, Polina Greenberg, Yishai Levin, Gil Benedek, Mitchell P Levesque, David J Adams, Mich

Identification of presented SARS-CoV-2 HLA class I and HLA class II peptides using HLA peptidomics

使用 HLA 肽组学鉴定 SARS-CoV-2 HLA I 类和 HLA II 类肽

Adi Nagler, Shelly Kalaora, Chaya Barbolin, Anastasia Gangaev, Steven L C Ketelaars, Michal Alon, Joy Pai, Gil Benedek, Yfat Yahalom-Ronen, Noam Erez, Polina Greenberg, Gal Yagel, Aviyah Peri, Yishai Levin, Ansuman T Satpathy, Erez Bar-Haim, Nir Paran, Pia Kvistborg, Yardena Samuels

Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanoma

免疫蛋白酶体表达与黑色素瘤患者更好的预后和对免疫检查点疗法的反应相关。

Shelly Kalaora # ,Joo Sang Lee # ,Eilon Barnea ,Ronen Levy ,Polina Greenberg ,Michal Alon ,Gal Yagel ,Gitit Bar Eli ,Roni Oren ,Aviyah Peri ,Sushant Patkar ,Lital Bitton ,Steven A Rosenberg ,Michal Lotem ,Yishai Levin ,Arie Admon ,Eytan Ruppin ,Yardena Samuels